Key Market Indicators
Swedish antirheumatic medicine sales are forecast to drop to $74 million by 2026. The market has decreased by an average of 1.2% year on year since 2021, when it stood at $79.3 million. This represents a 3.2% drop since 2005. The Czech Republic overtook Sweden in 2021 with sales of $79.3 million, and Germany, Spain, and Canada ranked second, third, and fourth respectively.
